Navigation Links
Sun Pharmaceutical Extends Tender Offer for Taro
Date:3/20/2009

19, 2009, 31,428 Ordinary Shares had been tendered and not withdrawn from the Offer.

The complete terms and conditions of the Tender Offer are set out in the Offer to Purchase, which is filed with the U.S. Securities and Exchange Commission. Taro shareholders may obtain copies of all of the offering documents, including the Offer to Purchase, free of charge at the SEC's website (www.sec.gov) or by directing a request to MacKenzie Partners, Inc., the Information Agent for the offer, at 105 Madison Avenue, New York, New York 10016, (212) 929-5500 (Call Collect) or Call Toll-Free (800) 322-2885, Email: tenderoffer@mackenziepartners.com.

Greenhill & Co., LLC is acting as the Dealer Manager for the Tender Offer and MacKenzie is acting as the Information Agent for the Tender Offer.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, U.S. and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, and orthopedics. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.

    Contacts

    Uday Baldota               
'/>"/>
SOURCE Sun Pharmaceutical Industries, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... game with knights, nature, and peasants. , The ... to Eurogamer. The popularity of these games grew over ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs has prepared ... UniWigs during the Easter Holidays from today until April ... April Fools’ Day. , As the winter fades and ... Easter Festival, with religious origins to countries in Europe ... Christmas. The best wig provider, UniWigs, would like to ...
(Date:3/28/2015)... 2015 Centurion Service Group will be hosting ... April 2 at their Las Vegas warehouse, located at 4606 ... sale, which consists of equipment from hospitals and surgery centers ... a.m. PDT. , Buyers will find items of all ... are a one-stop-shop,” said Erik Tivin, CEO of Centurion. , ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 Delaying ... not be necessary, according to research presented today at ... ) Specialty Day. , “Our study compared results for ... who underwent an additional glenohumeral joint capsule release procedure ... George Murrell MD, PhD, lead author from St. George ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Lately the ... media regarding recent changes and proposals around the NCAA. ... current and former collegiate student-athletes across a spectrum of ... reflect on common challenges. The special panel consists of ... in sports ranging from football, track and field, baseball, ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
... A novel technology for delivering nicotine to the lungs may ... When compared to the nicotine vapor delivery system ... effective at delivering nicotine to the blood stream. As a ... Duke University Medical Center researchers. Users also reported the new ...
... ... Design Automation to their growing family of RDM distributors. With offices throughout India, Icon ... , ... (PRWEB) February 27, 2010 -- Raima, a Birdstep Technology Company (OSE: BIRD), which ...
... ... ... ... ...
... ... drug Avandia® suffer heart attacks and heart failure as result of its use. ... ... Firm attorneys are investigating possible Avandia® claims. Contact an experienced personal injury lawyer ...
... , , ... ... ... , ...
... looks promising in lab tests, researchers say , FRIDAY, ... die soon after diagnosis, but researchers have identified an ... target. , Even more hopeful is that drugs that ... arthritis and are undergoing tests with colon and lung ...
Cached Medicine News:Health News:New smoking cessation therapy proves promising 2Health News:Icon Design Automation of India Joins the Growing Worldwide Network of Raima Resellers 2Health News:Icon Design Automation of India Joins the Growing Worldwide Network of Raima Resellers 3Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 2Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 3Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 4Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 5Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 6Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 7Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 8Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 9Health News:International Collaboration: FDA and European Medicines Agency Agree to Accept a Single Orphan Drug Designation Annual Report 10Health News:Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia 2Health News:Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia 3Health News:American National Announces Corrected Dividend Dates 2Health News:New Treatment Eyed for Deadly Pancreatic Cancer 2Health News:New Treatment Eyed for Deadly Pancreatic Cancer 3
(Date:3/27/2015)... , March 27, 2015 Biopharmaceutical ... The biopharmaceutical industry comes out on top as the ... a new report  from ndp│analytics. According to the  ... development (R&D) investment over the last decade, accounting for ... A Short Video on Medicare ...
(Date:3/27/2015)... , March 27, 2015 Zimmer Holdings, Inc. (NYSE and SIX: ... ® Complete Knee System. ... 20 th year since Zimmer first introduced the NexGen ... To date, more than five million implantations of the NexGen ... of the NexGen knee demonstrates the importance of design innovation ...
(Date:3/27/2015)... , March 27, 2015  Valeant Pharmaceuticals International, Inc. ... closing of its previously announced registered offering of common ... (the "Offering"). Pursuant to the Offering, the Company issued ... share, for aggregate gross proceeds of approximately $1.45 billion. ... U.S. Securities and Exchange Commission a final prospectus supplement ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3
... 2007 /PRNewswire/ -- DNA Therapeutics,S.A. an emerging pharmaceutical ... elucidation of a new mechanism,of action and the ... molecule Dbait. It will be,presented at the forecoming ... abstract is now available online.,The presentation itself will ...
... Potent Synergy, Activity and Patient Tolerance Support ... Spain, April 12, 2007 /PRNewswire/ -- Intarcia,Therapeutics, ... final results from a Phase 2 study ... treatment-naive patients,with genotype 1 chronic hepatitis C. ...
Cached Medicine Technology:DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 2DNA Therapeutics Reports a Novel Mechanism of Action and a,Biomarker of its Lead Molecule Dbait That Open an Innovative,Pathway-Targeting in Molecular Cancer Therapy 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 2Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 3Intarcia Therapeutics Announces Final Results From a Phase 2 Study,of Injectable Omega Interferon plus Ribavirin for the Treatment of,Hepatitis C Genotype-1 4
... ChartMaker is a modular, Electronic Medical Record ... Windows to create a patient chart. ChartMaker ... E & M compliant patient notes, medical reports, ... template driven, ChartMaker is designed to be installed ...
Clinician's Desktop provides users the tools needed to coordinate information. Utilizing client/server technology Clinicians Desktop provides users with electronic medical records....
... EMR is an innovative solution for automating ... It can be populated with Clinical Pathways ... particular medical specialty. Following these Clinical Pathways, ... easy as "point and click" on a ...
... With Patient Chart Manager information can ... room. You are not limited to ... Manager allows each person to document ... staff enter valuable data and communication. ...
Medicine Products: